Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndrome

There are no proven safe and effective therapies for children who develop life-threatening complications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Convalescent plasma (CP) has demonstrated potential benefit in adults with SARS-CoV-2, but has theoretical risks.We present the fi...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Pediatr Blood Cancer
Auteurs principaux: Diorio, Caroline, Anderson, Elizabeth M., McNerney, Kevin O., Goodwin, Eileen C., Chase, Julie C., Bolton, Marcus J., Arevalo, Claudia P., Weirick, Madison E., Gouma, Sigrid, Vella, Laura A., Henrickson, Sarah E., Chiotos, Kathleen, Fitzgerald, Julie C., Kilbaugh, Todd J., Odom John, Audrey R., Blatz, Allison M., Lambert, Michele P., Sullivan, Kathleen E., Tartaglione, Margaret R., Zambrano, Danielle, Martin, Meghan, Lee, Jessica H., Young, Pampee, Friedman, David, Sesok-Pizzini, Deborah A., Hensley, Scott E., Behrens, Edward M., Bassiri, Hamid, Teachey, David T.
Format: Artigo
Langue:Inglês
Publié: 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7734626/
https://ncbi.nlm.nih.gov/pubmed/32885904
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.28693
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires